Home
Tara Helen Dowling's picture

Tara Helen Dowling

PhD Candidate
  • E-mailTara.Dowling@uib.no
  • Visitor Address
    Haukeland University Hospital
    Laboratory Buiding
    N-5020 Bergen
    Room 
    3210
  • Postal Address
    Postboks 7804
    5020 Bergen

Work is performed in the subgroup PRELIM in Translational Molecular Imaging of Cancer(Prof. McCormack) and in the Signalling targeted therapy group(Prof. Gjertsen)

Affiliated with CCBIO

https://www.uib.no/en/rg/tmic 

https://www.uib.no/en/ccbio/73500/signalling-targeted-therapy

Laboratory assistant teacher in Galenic Pharmacy (FARM295)

Journal articles
  • Bjørnstad, Ronja; Aesoy, Reidun; Bruserud, Øystein; Brenner, Annette; Giraud, Francis; Dowling, Tara Helen; Gausdal, Gro; Moreau, Pascale; Doskeland, Stein Ove; Anizon, Fabrice; Herfindal, Lars. 2019. A kinase inhibitor with anti-Pim kinase activity is a potent and selective cytotoxic agent toward acute myeloid leukemia. Molecular Cancer Therapeutics. 18: 567-578. doi: 10.1158/1535-7163.MCT-17-1234
  • Forthun, Rakel Brendsdal; Hinrichs, Carina; Dowling, Tara Helen; Bruserud, Øystein; Selheim, Frode. 2016. The past, present and future subclassification of patients with acute Myeloid Leukemia. Current Pharmaceutical Biotechnology. 17: 6-19. doi: 10.2174/1389201016666150907113653

More information in national current research information system (CRIStin)

  • B.Sc in Biology at the University of Bergen (2013)
  • M.Sc in Biomedicine - Medical cell Biology at the University of Bergen (2015) with the thesis "Exploring the anti-leukaemic effect of the small-molecule dynamin GTPase inhibitor; Dynasore, in Acute Myeloid Leukaemia."